| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |